Terms: = Kidney tumors AND ZBTB16, Q05516, 7704, ENSG00000109906, ZNF145, PLZF
4 results:
1. Cell Differentiation Trajectory Predicts Prognosis and Immunotherapeutic Response in Clear Cell Renal Cell Carcinoma.
Xu J; Chen X; Chen Y; Wang Q; Jin Y; Zhao H
Genet Res (Camb); 2022; 2022():8422339. PubMed ID: 36530957
[TBL] [Abstract] [Full Text] [Related]
2. zbtb16: A new biomarker for primitive neuroectodermal tumor element / Ewing sarcoma.
Xiao GQ; Sherrod AE; Hurth KM
Pathol Res Pract; 2019 Oct; 215(10):152536. PubMed ID: 31326195
[TBL] [Abstract] [Full Text] [Related]
3. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses.
Whitson JM; Harris CR; Meng MV
BJU Int; 2012 Nov; 110(10):1438-43; discussion 1443. PubMed ID: 22639860
[TBL] [Abstract] [Full Text] [Related]
4. Under-grading of <4 cm renal masses on renal biopsy.
Harris CR; Whitson JM; Meng MV
BJU Int; 2012 Sep; 110(6):794-7. PubMed ID: 22404857
[TBL] [Abstract] [Full Text] [Related]
